Oily fish, such as salmon, has the highest amounts of omega-3, or good fats.
Friday night fish fries may end after Lent, but that doesn’t mean your commitment to eating fish on Fridays has to stop …
The American Heart Association recommends eating at least two servings of fish per week (particularly fatty, or oily, fish) to reduce the risk of death from heart disease and stroke. So why not continue a good thing by keeping fish on your Friday menu?
And, remember, the best fish to eat for heart health is oily fish. Here’s why:
While all fish provide protein and omega-3 fatty acids, salmon and other oily fish — sardines, tuna, mackerel, bluefish, rainbow trout and herring — have the highest amounts. These “good fats” benefit the hearts of healthy people, and those who have, or are at high risk for, cardiovascular disease. Research has shown that omega-3 fatty acids decrease the risk of abnormal heartbeats (arrhythmias), which can lead to sudden death. Omega-3 fatty acids also decrease triglyceride levels, slow growth rate of atherosclerotic plaque and lower blood pressure. Continue reading →
mCancerPartner sat down recently with Khaled S. Hafez, M.D., a surgeon and associate professor of urology, to discuss how kidney cancer is detected and the role biopsies play.
mCancerPartner: What are the symptoms of kidney cancer?
Dr. Hafez: The three symptoms that normally indicate kidney cancer are pain in the abdomen, blood in the urine and a mass, or growth, in the side. But how physicians find kidney cancer has changed in recent years. Today, most kidney cancer is found accidently, before the symptoms Continue reading →
Most of us don’t give our voices a second thought, even though we use them every day to talk, sing, shout, laugh, hum or scream.
But Norman Hogikyan, M.D., spends every day thinking about voices: those of his patients.
As director of the U-M Vocal Health Center, he treats everyone from teachers to opera singers for ailments that affect their speaking and singing ability. Too many people abuse their voices, he says, or fail to recognize changes in their voice that actually signal some greater danger.
This week, in honor of World Voice Day, he offers top tips and other information to help us all get educated about vocal health.
Living with a chronic illness often means taking medication…sometimes, a lot of medication.
In this week’s new Kids4Kids video, patients from C.S. Mott Children’s Hospital talk about their experiences keeping up with complicated medicine regimens, and some of the tips they’ve used to stay on top of taking meds.
What tips do you have for kids and teens on keeping up with medications and treatment regimens? Use the “reply” tool at the bottom of this post to share your advice with others!
Schedule your vein treatment consultation now to get your legs ready for summer.
This is the time of year when long pants and warm socks are replaced with summer shorts and sandals. It is also the time of year when many patients come to the University of Michigan Vein Centers for a vein treatment consultation, wanting to know what they can do to get their legs looking and feeling great. Often, they are concerned with the appearance of spider and varicose veins, which impact more than 30 million adults in the United States.
The key is to schedule your vein treatment consultation a few months in advance, as some treatment options require follow-up and/or time to heal.
A visit to the University of Michigan Livonia Vein Center usually begins with an exam by one of our experienced providers, who will gather information about your vein health and share information about caring for your legs. In some cases, an ultrasound study of your legs may be necessary. Then, a personalized treatment plan is designed specifically for you.
New varicose vein treatment on the horizon
Varithena® is recently FDA-approved for foam sclerotherapy and has been shown to improve the symptoms and appearance of varicose veins. This treatment — a minimally invasive, non-surgical procedure that features injecting the varicose vein — is expected to be available this summer. Continue reading →
Human KRAS protein. Mutant RAS proteins may play a role in one third of all human cancers.
Mutation of the KRAS gene drives up to 30% of all human cancers, and is especially prevalent among aggressive and hard-to-treat forms — like pancreatic, colon and lung cancers. For decades, researchers have tried to develop drugs to shut down the mutated gene, but a lack of success by pharmaceutical, biotech and academic laboratories has earned this cancer mutation a reputation for being “undruggable.”
New research conducted at the University of Michigan, however, offers a new strategy for disrupting the mutations’ unchecked spread — by attacking a protein complex that protects and supports it. The approach, detailed in a forthcoming article in Neoplasia[DI1] , comes as efforts to combat the mutation have been in the national spotlight. Recently, the National Cancer Institute announced a $10 million-a-year initiative to target KRAS, for which it is repurposing a new high-tech lab at the Frederick National Laboratory for Cancer Research. Continue reading →